This is a pilot feasibility study and the objective is to evaluate the safety and effectiveness of the investigational device, IN.PACT 014 drug-coated balloon, compared with standard PTA in patients with CLI with CTOs of BTK arteries.
This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD.
Previous studies have suggested that Black patients with peripheral artery disease (PAD) may have worse outcomes than White patients. The aim of this study was to determine whether there are racial differences in outcomes of patients with PAD undergoing endovascular treatment.
We present a case of ostial superficial femoral artery CTO in a patient with CLI who underwent successful revascularization via TCIA strategy with a successful outcome.
We present 5 elderly patients with varying severity of acute respiratory distress syndrome due to SARS-CoV-2. During hospitalization, each patient experienced acute arterial ischemia of the lower extremity despite anticoagulation therapy, requiring surgical intervention.
This analysis seeks to describe the technique of ultrasound-assisted percutaneous superficial femoral arterial access closure with a Mynx device (Cordis Corporation). The study aim was to demonstrate the technical considerations, benefits, efficacy, and safety of this technique.